Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ICBS, Ltd. is a Canadian-based company that operates as a strategic incubator and investment firm specializing in high-growth opportunities within the life sciences and technology sectors. The company employs a three-pronged business model focused on acquiring undervalued assets, acting as an incubator for emerging firms, and taking minority interests in partner companies to align with long-term growth. A primary focus of ICBS has been its partnership with BioSpec Global Solutions, which develops state-of-the-art, rapid onsite monitoring technologies for detecting microbial contamination in water, food, and pharmaceutical applications. Its flagship products, the TOGS 3000 and TOGS 9000, utilize Time of Growth Spectrophotometry for the automated detection of pathogens like E. coli and Listeria. ICBS is publicly traded on the OTC Pink market under the symbol ICBT.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ICBS.